• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

G 蛋白调节内源性大麻素释放:G 蛋白偶联受体作用的旁分泌机制。

Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action.

机构信息

Department of Physiology, Semmelweis University, Budapest, Hungary.

出版信息

Mol Cell Endocrinol. 2012 Apr 28;353(1-2):29-36. doi: 10.1016/j.mce.2011.10.011. Epub 2011 Nov 2.

DOI:10.1016/j.mce.2011.10.011
PMID:22075205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4169275/
Abstract

In the past years, the relationship between the endocannabinoid system (ECS) and other hormonal and neuromodulatory systems has been intensively studied. G protein-coupled receptors (GPCRs) can stimulate endocannabinoid (eCB) production via activation of G(q/11) proteins and, in some cases, G(s) proteins. In this review, we summarize the pathways through which GPCR activation can trigger eCB release, as well as the best known examples of this process throughout the body tissues. Angiotensin II-induced activation of AT(1) receptors, similar to other G(q/11)-coupled receptors, can lead to the formation of 2-arachidonoylglycerol (2-AG), an important eCB. The importance of eCB formation in angiotensin II action is supported by the finding that the hypertensive effect of angiotensin II, injected directly into the hypothalamic paraventricular nucleus of anaesthetized rats, can be abolished by AM251, an inverse agonist of CB(1) cannabinoid receptors (CB(1)Rs). We conclude that activation of the ECS should be considered as a general consequence of the stimulation of G(q/11)-coupled receptors, and may mediate some of the physiological effects of GPCRs.

摘要

在过去的几年中,内源性大麻素系统(ECS)与其他激素和神经调制系统之间的关系已得到深入研究。G 蛋白偶联受体(GPCR)可通过激活 G(q/11)蛋白,在某些情况下通过 G(s)蛋白来刺激内源性大麻素(eCB)的产生。在这篇综述中,我们总结了 GPCR 激活触发 eCB 释放的途径,以及在全身组织中这一过程的一些最为人熟知的例子。血管紧张素 II 诱导的 AT(1)受体激活,与其他 G(q/11)偶联受体相似,可导致 2-花生四烯酸甘油(2-AG)的形成,这是一种重要的 eCB。血管紧张素 II 直接注射到麻醉大鼠下丘脑室旁核引起的高血压效应可被 AM251 (CB(1)大麻素受体的反向激动剂)消除,这一发现支持了 eCB 形成在血管紧张素 II 作用中的重要性。我们得出结论,ECS 的激活应被视为 G(q/11)偶联受体刺激的一般后果,并且可能介导 GPCR 的一些生理效应。

相似文献

1
Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action.G 蛋白调节内源性大麻素释放:G 蛋白偶联受体作用的旁分泌机制。
Mol Cell Endocrinol. 2012 Apr 28;353(1-2):29-36. doi: 10.1016/j.mce.2011.10.011. Epub 2011 Nov 2.
2
Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors.AT1血管紧张素及其他Gq/11蛋白偶联受体对CB1大麻素受体的旁分泌反式激活作用
J Biol Chem. 2009 Jun 19;284(25):16914-16921. doi: 10.1074/jbc.M109.003681. Epub 2009 Apr 7.
3
Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension.内源性大麻素介导的对Gq/11蛋白偶联受体信号传导诱导的血管收缩和高血压的调节。
Mol Cell Endocrinol. 2015 Mar 5;403:46-56. doi: 10.1016/j.mce.2015.01.012. Epub 2015 Jan 13.
4
Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat.内源性2-花生四烯酸甘油酯作为一种内源性大麻素在(±)-埃博霉素诱导大鼠中枢肾上腺髓质传出神经激活中的可能抑制作用。
Neuropharmacology. 2015 Aug;95:278-89. doi: 10.1016/j.neuropharm.2015.03.034. Epub 2015 Apr 14.
5
Involvement of the endocannabinoid system in periodontal healing.内源性大麻素系统在牙周愈合中的作用。
Biochem Biophys Res Commun. 2010 Apr 16;394(4):928-33. doi: 10.1016/j.bbrc.2010.03.080. Epub 2010 Mar 15.
6
Endocannabinoids modulate G protein-coupled receptor agonist-induced vasoconstriction via a negative feedback mechanism.内源性大麻素通过负反馈机制调节 G 蛋白偶联受体激动剂诱导的血管收缩。
J Pharm Pharmacol. 2018 Feb;70(2):214-222. doi: 10.1111/jphp.12854. Epub 2017 Nov 17.
7
Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus.伏隔核壳内源性大麻素系统的药理学增强刺激食物摄入并增加下丘脑c-Fos表达。
Br J Pharmacol. 2007 Aug;151(7):1109-16. doi: 10.1038/sj.bjp.0707313. Epub 2007 Jun 4.
8
Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors.血管紧张素 II 诱导血管内源性大麻素释放,通过 CB1 大麻素受体减弱其血管收缩作用。
J Biol Chem. 2012 Sep 7;287(37):31540-50. doi: 10.1074/jbc.M112.346296. Epub 2012 Jul 11.
9
Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.星状细胞衍生的内源性大麻素对肝脏CB1受体的旁分泌激活介导酒精性脂肪肝。
Cell Metab. 2008 Mar;7(3):227-35. doi: 10.1016/j.cmet.2007.12.007.
10
Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia.5 型代谢型谷氨酸受体和二酰基甘油脂肪酶-α的激活引发 2-花生四烯酸甘油的形成和内源性大麻素介导的镇痛作用。
J Neurosci. 2012 Jul 11;32(28):9457-68. doi: 10.1523/JNEUROSCI.0013-12.2012.

引用本文的文献

1
Investigating the Role of Cannabinoid Type 1 Receptors in Vascular Function and Remodeling in a Hypercholesterolemic Mouse Model with Low-Density Lipoprotein-Cannabinoid Type 1 Receptor Double Knockout Animals.研究低密度脂蛋白-大麻素 1 型受体双敲除动物的高胆固醇血症小鼠模型中大麻素 1 型受体在血管功能和重塑中的作用。
Int J Mol Sci. 2024 Sep 2;25(17):9537. doi: 10.3390/ijms25179537.
2
Role of CB1 Cannabinoid Receptors in Vascular Responses and Vascular Remodeling of the Aorta in Female Mice.CB1 cannabinoid 受体在雌性小鼠主动脉血管反应和血管重塑中的作用。
Int J Mol Sci. 2023 Nov 17;24(22):16429. doi: 10.3390/ijms242216429.
3

本文引用的文献

1
Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A.大麻素 CB(1) 受体和食欲素 OX(1) 受体的异源三聚体化产生了一个独特的复合物,其中两个前体都受食欲素 A 的调节。
J Biol Chem. 2011 Oct 28;286(43):37414-28. doi: 10.1074/jbc.M111.287649. Epub 2011 Sep 9.
2
AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II.血管紧张素 II 的致病特性的新机制:AT1R-CB₁R 异聚体。
EMBO J. 2011 May 3;30(12):2350-63. doi: 10.1038/emboj.2011.139.
3
Supply and demand for endocannabinoids.
Role of the Endocannabinoid System in Metabolic Control Processes and in the Pathogenesis of Metabolic Syndrome: An Update.
内源性大麻素系统在代谢控制过程及代谢综合征发病机制中的作用:最新进展
Biomedicines. 2023 Jan 21;11(2):306. doi: 10.3390/biomedicines11020306.
4
Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance.内源性大麻素系统与肾素-血管紧张素系统的串扰:基础证据与潜在治疗意义。
Int J Mol Sci. 2022 Jun 6;23(11):6350. doi: 10.3390/ijms23116350.
5
Cross-Talk between CB, AT, AT and Mas Receptors Responsible for Blood Pressure Control in the Paraventricular Nucleus of Hypothalamus in Conscious Spontaneously Hypertensive Rats and Their Normotensive Controls.在清醒自发性高血压大鼠和其正常血压对照的下丘脑室旁核中,负责血压控制的 CB、AT、AT 和 Mas 受体之间的串扰。
Cells. 2022 May 4;11(9):1542. doi: 10.3390/cells11091542.
6
Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox.大麻素受体 1 抑制在慢性肾脏病中的应用:一个新的治疗工具箱。
Front Endocrinol (Lausanne). 2021 Jul 7;12:720734. doi: 10.3389/fendo.2021.720734. eCollection 2021.
7
Cannabinoids in the landscape of cancer.大麻素在癌症领域的应用。
J Cancer Res Clin Oncol. 2021 Sep;147(9):2507-2534. doi: 10.1007/s00432-021-03710-7. Epub 2021 Jul 14.
8
Angiotensin II-Induced Cardiac Effects Are Modulated by Endocannabinoid-Mediated CB Receptor Activation.血管紧张素 II 诱导的心脏效应受内源性大麻素介导的 CB 受体激活调节。
Cells. 2021 Mar 24;10(4):724. doi: 10.3390/cells10040724.
9
Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases.大麻素受体:在神经、心血管和炎症性疾病中的细胞信号、病理生理作用和治疗机会方面的最新进展。
Int J Mol Sci. 2020 Oct 17;21(20):7693. doi: 10.3390/ijms21207693.
10
The neuropharmacology of cannabinoid receptor ligands in central signaling pathways.大麻素受体配体在中枢信号通路中的神经药理学。
Eur J Neurosci. 2022 Feb;55(4):909-921. doi: 10.1111/ejn.14982. Epub 2020 Dec 5.
内源性大麻素的供需。
Trends Neurosci. 2011 Jun;34(6):304-15. doi: 10.1016/j.tins.2011.03.003. Epub 2011 Apr 18.
4
Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists.个性化医疗可以为 CB₁ 受体拮抗剂的安全使用铺平道路。
Trends Pharmacol Sci. 2011 May;32(5):270-80. doi: 10.1016/j.tips.2011.02.013. Epub 2011 Apr 16.
5
Neuronal protease-activated receptor 1 drives synaptic retrograde signaling mediated by the endocannabinoid 2-arachidonoylglycerol.神经元蛋白酶激活受体 1 驱动由内源性大麻素 2-花生四烯酰甘油介导的突触逆行信号转导。
J Neurosci. 2011 Feb 23;31(8):3104-9. doi: 10.1523/JNEUROSCI.6000-10.2011.
6
Endogenously generated 2-arachidonoylglycerol plays an inhibitory role in bombesin-induced activation of central adrenomedullary outflow in rats.内源性生成的 2-花生四烯酸甘油发挥抑制作用,在蛙皮素诱导的大鼠中枢肾上腺素髓质流出的激活。
Eur J Pharmacol. 2011 May 11;658(2-3):123-31. doi: 10.1016/j.ejphar.2011.02.023. Epub 2011 Mar 1.
7
Requirement for CB1 but not GABAB receptors in the cholecystokinin mediated inhibition of GABA release from cholecystokinin expressing basket cells.胆囊收缩素表达篮状细胞中胆囊收缩素介导的 GABA 释放抑制作用需要 CB1 受体而不是 GABAB 受体。
J Physiol. 2011 Feb 15;589(Pt 4):891-902. doi: 10.1113/jphysiol.2010.198499. Epub 2010 Dec 20.
8
Opposing actions of endothelin-1 on glutamatergic transmission onto vasopressin and oxytocin neurons in the supraoptic nucleus.内皮素-1 对神经垂体加压素和催产素神经元谷氨酸能传递的相反作用。
J Neurosci. 2010 Dec 15;30(50):16855-63. doi: 10.1523/JNEUROSCI.5079-10.2010.
9
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.国际基础和临床药理学联合会. LXXIX. 大麻素受体及其配体:超越 CB₁ 和 CB₂。
Pharmacol Rev. 2010 Dec;62(4):588-631. doi: 10.1124/pr.110.003004.
10
Possible inhibitory roles of endogenous 2-arachidonoylglycerol during corticotropin-releasing factor-induced activation of central sympatho-adrenomedullary outflow in anesthetized rats.内源性 2-花生四烯酸甘油在麻醉大鼠中促肾上腺皮质释放因子诱导的中枢交感神经肾上腺髓质流出激活中的可能抑制作用。
Eur J Pharmacol. 2010 Sep 1;641(1):54-60. doi: 10.1016/j.ejphar.2010.05.007. Epub 2010 May 25.